Cellular characterization of ultrasound-stimulated microbubble radiation enhancement in a prostate cancer xenograft model

DMM Disease Models and Mechanisms

Volumn 7, Issue 3, 2014, Pages 363-372

  Al Mahrouki, Azza A ^a   Iradji, Sara ^a   Tran, William Tyler ^a,b   Czarnota, Gregory J ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Angiogenesis; Microbubbles; Proliferation; Radiation; Ultrasound

Indexed keywords

CERAMIDE; DNA NUCLEOTIDYLEXOTRANSFERASE; OXYGEN; OXYGENASE; VASCULOTROPIN; CD31 ANTIGEN; EGLN1 PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR PROLINE DIOXYGENASE; KI 67 ANTIGEN; TUMOR MARKER; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ECHOGRAPHY; HISTOPATHOLOGY; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MICROBUBBLE; MOUSE; NICK END LABELING; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION; TREATMENT RESPONSE; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; ANIMAL; BIOLOGICAL MODEL; CELL HYPOXIA; DRUG SCREENING; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROSTATIC NEOPLASMS; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUNEL ASSAY; ULTRASOUND; VASCULARIZATION;

ANIMALS; ANTIGENS, CD31; BIOMARKERS, TUMOR; CELL DEATH; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CERAMIDES; DNA DAMAGE; HUMANS; HYPOXIA-INDUCIBLE FACTOR-PROLINE DIOXYGENASES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MICE, SCID; MICROBUBBLES; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; ULTRASONICS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84897124440     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.012922     Document Type: Article

References (51)

1. Al-Mahrouki, A. A., Karshafian, R., Giles, A. and Czarnota, G. J. (2012). Bioeffects of ultrasound-stimulated microbubbles on endothelial cells: gene expression changes associated with radiation enhancement in vitro. Ultrasound Med. Biol. 38, 1958-1969.
2. Badea, R., Seicean, A., Diaconu, B., Stan-Iuga, R., Sparchez, Z., Tantau, M. and Socaciu, M. (2009). Contrast-enhanced ultrasound of the pancreas - a method beyond its potential or a new diagnostic standard? J. Gastrointestin. Liver Dis. 18, 237-242.
3. Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D. and Rich, J. N. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760. (Pubitemid 44949604)
4. Bastianutto, C., Mian, A., Symes, J., Mocanu, J., Alajez, N., Sleep, G., Shi, W., Keating, A., Crump, M., Gospodarowicz, M. et al. (2007). Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow. Cancer Res. 67, 10112-10116. (Pubitemid 350070781)
5. Becher, O. J., Hambardzumyan, D., Walker, T. R., Helmy, K., Nazarian, J., Albrecht, S., Hiner, R. L., Gall, S., Huse, J. T., Jabado, N. et al. (2010). Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma. Cancer Res. 70, 2548-2557.
6. Bos, P. D., Zhang, X. H., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A. et al. (2009). Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005-1009.
7. Briggs, K., Al Mahrouki, A., Nofiele, J., El-Falou, A., Stanisz, M., Kim, H. C., Kolios, M. C. and Czarnota, G. J. (2013). Non-invasive monitoring of ultrasound-stimulated microbubble radiation enhancement using photoacoustic imaging. Technol. Cancer Res. Treat. [Epub ahead of print] DOI: 10.7785/tcrtexpress.2013.600266.
8. Butterworth, K. T., McCarthy, H. O., Devlin, A., Ming, L., Robson, T., McKeown, S. R. and Worthington, J. (2008). Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype. Int. J. Cancer 123, 760-768. (Pubitemid 352032400)
9. Cébe-Suarez, S., Zehnder-Fjällman, A. and Ballmer-Hofer, K. (2006). The role of VEGF receptors in angiogenesis; complex partnerships. Cell. Mol. Life Sci. 63, 601-615.
10. Cervi, D., Shaked, Y., Haeri, M., Usenko, T., Lee, C. R., Haigh, J. J., Nagy, A., Kerbel, R. S., Yefenof, E. and Ben-David, Y. (2007). Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia. Blood 109, 2139-2146. (Pubitemid 46348216)
11. Connell, P. P. and Hellman, S. (2009). Advances in radiotherapy and implications for the next century: a historical perspective. Cancer Res. 69, 383-392.
12. Cosgrove, D. (2006). Ultrasound contrast agents: an overview. Eur. J. Radiol. 60, 324-330.
13. Czarnota, C. J., Karshafian, R., Burns, P. N. and Wong, S., Al-Mahrouki, A., Lee, J. W., Caissie, A., Tran, W., Kim, C., Furukawa, M. et al. (2012). Tumor radiation response enhancement by acoustical stimulation of the vasculature. Proc. Natl. Acad. Sci. 109, 11904-11905.
14. Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M. et al. (2009). Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458, 780-783.
15. Diepart, C., Karroum, O., Magat, J., Feron, O., Verrax, J., Calderon, P. B., Grégoire, V., Leveque, P., Stockis, J., Dauguet, N. et al. (2012). Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors. Cancer Res. 72, 482-490.
16. Dow, L. W., Bhakta, M. and Wilimas, J. (1982). Clonogenic assay for Wilms' tumor: improved technique for obtaining single-cell suspensions and evidence for tumor cell specificity. Cancer Res. 42, 5262-5264. (Pubitemid 13223179)
17. Ebos, J. M., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G. and Kerbel, R. S. (2009). Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15, 232-239.
18. Folkman, J. and Camphausen, K. (2001). Cancer. What does radiotherapy do to endothelial cells? Science 293, 227-228. (Pubitemid 32694723)
19. Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z. and Kolesnick, R. (2003). Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300, 1155-1159. (Pubitemid 36583102)
20. Garden, A. S., Maor, M. H., Yung, W. K., Bruner, J. M., Woo, S. Y., Moser, R. P. and Lee, Y. Y. (1991). Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother. Oncol. 20, 99-110.
21. Goertz, D. E., Todorova, M., Mortazavi, O., Agache, V., Chen, B., Karshafian, R. and Hynynen, K. (2012). Antitumor effects of combining docetaxel (taxotere) with the antivascular action of ultrasound stimulated microbubbles. PLoS ONE 7, e52307.
22. Gravdal, K., Halvorsen, O. J., Haukaas, S. A. and Akslen, L. A. (2009). Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer. Cancer Res. 69, 4708-4715.
23. Haag, P., Frauscher, F., Gradl, J., Seitz, A., Schäfer, G., Lindner, J. R., Klibanov, A. L., Bartsch, G., Klocker, H. and Eder, I. E. (2006). Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. J. Steroid Biochem. Mol. Biol. 102, 103-113. (Pubitemid 44750646)
24. Hernot, S. and Klibanov, A. L. (2008). Microbubbles in ultrasound-triggered drug and gene delivery. Adv. Drug Deliv. Rev. 60, 1153-1166.
25. Huang, S. and Ingber, D. E. (1999). The structural and mechanical complexity of cellgrowth control. Nat. Cell Biol. 1, E131-E138.
26. Huang, Z., Mayr, N. A., Yuh, W. T., Lo, S. S., Montebello, J. F., Grecula, J. C., Lu, L., Li, K., Zhang, H., Gupta, N. et al. (2010). Predicting outcomes in cervical cancer: a kinetic model of tumor regression during radiation therapy. Cancer Res. 70, 463-470.
27. Ibsen, S., Schutt, C. E. and Esener, S. (2013). Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment. Drug Des Devel Ther 7, 375-388.
28. Jokilehto, T., Rantanen, K., Luukkaa, M., Heikkinen, P., Grenman, R., Minn, H., Kronqvist, P. and Jaakkola, P. M. (2006). Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. Clin. Cancer Res. 12, 1080-1087. (Pubitemid 43342495)
29. Kamat, A. A., Merritt, W. M., Coffey, D., Lin, Y. G., Patel, P. R., Broaddus, R., Nugent, E., Han, L. Y., Landen, C. N., Jr, Spannuth, W. A. et al. (2007). Clinical and biological significance of vascular endothelial growth factor in endometrial cancer. Clin. Cancer Res. 13, 7487-7495.
30. Karshafian, R., Bevan, P. D., Williams, R., Samac, S. and Burns, P. N. (2009). Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound Med. Biol. 35, 847-860.
31. Kee, N., Sivalingam, S., Boonstra, R. and Wojtowicz, J. M. (2002). The utility of Ki- 67 and BrdU as proliferative markers of adult neurogenesis. J. Neurosci. Methods 115, 97-105. (Pubitemid 34202283)
32. Kim, H.C., Al-Mahrouki, A., Gorjizadeh, A., Karshafian, R., Czarnota, G.J. (2013). Effects of biophysical parameters in enhancing radiation responses of prostate tumors with ultrasound-stimulated microbubbles. Ultrasound Med. Biol. 39, 1376-1387.
33. Korpanty, G., Carbon, J. G., Grayburn, P. A., Fleming, J. B. and Brekken, R. A. (2007). Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin. Cancer Res. 13, 323-330. (Pubitemid 46121886)
34. Leung, T. H. and Ngan, H. Y. (2010). Interaction of TAp73 and breast cancer-associated gene 3 enhances the sensitivity of cervical cancer cells in response to irradiation-induced apoptosis. Cancer Res. 70, 6486-6496.
35. Lukas, J., Lukas, C. and Bartek, J. (2011). More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance. Nat. Cell Biol. 13, 1161-1169.
36. Mammoto, A., Connor, K. M., Mammoto, T., Yung, C. W., Huh, D., Aderman, C. M., Mostoslavsky, G., Smith, L. E. and Ingber, D. E. (2009). A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 457, 1103-1108.
37. Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436-444.
38. Matthews, B. D., Overby, D. R., Mannix, R. and Ingber, D. E. (2006). Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels. J. Cell Sci. 119, 508-518.
39. Mazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y. M., Lanahan, A. A., Pollard, P., Ruiz de Almodovar, C. et al. (2009). Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839-851.
40. Miller, D. L., Dou, C., Sorenson, D. and Liu, M. (2011). Histological observation of islet hemorrhage induced by diagnostic ultrasound with contrast agent in rat pancreas. PLoS ONE 6, e21617.
41. Nofiele, J. T., Karshafian, R., Furukawa, M., Al Mahrouki, A., Giles, A., Wong, S. and Czarnota, G. J. (2013). Ultrasound-activated microbubble cancer therapy: ceramide production leading to enhanced radiation effect in vitro. Technol. Cancer Res. Treat. 12, 53-60.
42. Pàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D. and Casanovas, O. (2009). Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220-231.
43. Paris, F., Fuks, Z., Kang, A., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz- Friedman, A., Cordon-Cardo, C. and Kolesnick, R. (2001). Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293, 293-297. (Pubitemid 32694744)
44. Pchejetski, D., Bohler, T., Brizuela, L., Sauer, L., Doumerc, N., Golzio, M., Salunkhe, V., Teissié, J., Malavaud, B., Waxman, J. et al. (2010). FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1. Cancer Res. 70, 8651-8661.
45. Phillips, L. C., Klibanov, A. L., Wamhoff, B. R. and Hossack, J. A. (2010). Targeted gene transfection from microbubbles into vascular smooth muscle cells using focused, ultrasound-mediated delivery. Ultrasound Med. Biol. 36, 1470-1480.
46. Reynolds, A. R., Hart, I. R., Watson, A. R., Welti, J. C., Silva, R. G., Robinson, S. D., Da Violante, G., Gourlaouen, M., Salih, M., Jones, M. C. et al. (2009). Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat. Med. 15, 392-400.
47. Spiegelhalter, D., Pearson, M. and Short, I. (2011). Visualizing uncertainty about the future. Science 333, 1393-1400.
48. Tran, W. T., Iradji, S., Sofroni, E., Giles, A., Eddy, D. and Czarnota, G. J. (2012). Microbubble and ultrasound radioenhancement of bladder cancer. Br. J. Cancer 107, 469-476.
49. Wei, D., Li, H., Yu, J., Sebolt, J. T., Zhao, L., Lawrence, T. S., Smith, P. G., Morgan, M. A. and Sun, Y. (2012). Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Cancer Res. 72, 282-293.
50. Wijsman, J. H., Jonker, R. R., Keijzer, R., van de Velde, C. J., Cornelisse, C. J. and van Dierendonck, J. H. (1993). A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J. Histochem. Cytochem. 41, 7-12. (Pubitemid 23014194)
51. Zlobec, I., Höller, S., Tornillo, L., Terracciano, L. and Lugli, A. (2009). Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer. Dis. Colon Rectum 52, 1114-1121.